ArticlePolymers2025
Preparation of Alginate/AgNP Nanocomposite Hydrogels Incorporating Olive Leaf Extracts in Natural Deep Eutectic Solvents.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the present study, alginate-silver nanoparticle (Alg-AgNP) nanocomposite hydrogels possessing antibacterial activity were synthesized via an innovative route. A task-specific designed Natural Deep Eutectic Solvent (NADES), composed of glucose, lactic acid, and water, was utilized as a green extraction solvent of bioactive compounds from olive leaves (OLs). The NADES-olive leaf extract (NADES-OLE) was used as obtained for the preparation of the Alg-AgNP nanocomposite hydrogel as a multiple-role component. The NADES-OLE acts (a) as a crosslinking agent for the preparation of the alginate hydrogels, (b) as a reducing agent for the in situ synthesis of AgNPs during hydrogel formation, and (c) as a bioactivity enhancement agent due to the presence of compounds obtained from the olive leaves. The Alg-AgNP hydrogel preparation process was optimized through a Box-Behnken experimental design. The resulting nanocomposite hydrogels were characterized for their swelling capacity and water retention in phosphate buffer (pH 5.5), achieving 538% swelling capacity within 180 min and 90% water retention after 250 min. The AgNPs formed within the hydrogels were found to have an average size of 103.2 ± 5.6 nm, with a concentration of 1.2 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.